Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer

Journal of the National Cancer Institute

Volumn 90, Issue 22, 1998, Pages 1729-1734

  Webb, Penelope M ^a   Green, Adèle ^b   Cummings, Margaret C ^a   Purdie, David M ^a   Walsh, Michael D ^a   Chenevix Trench, Georgia ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENSTRUAL CYCLE; OVARY CANCER; OVULATION; PRIORITY JOURNAL;

EID: 0032545050     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.22.1729     Document Type: Article

References (13)

1. Fathalla MF. Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971;2:163.
2. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1212-20.
3. Whittemore AS, McGuire V. Ovulation, p53 mutations, and ovarian cancer - a causal link? [editorial]. J Natl Cancer Inst 1997;89: 906-7.
4. Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, et al. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst 1993;85:1513-9.
5. Jones PA, Buckley JD, Henderson BE, Ross RK, Pike MC. From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res 1991;51:3617-20.
6. Godwin AK, Testa JR, Hamilton TC. The biology of ovarian cancer development. Cancer 1993;71(2 Suppl):530-6.
7. Schildkraut JM, Bastos E, Berchuck A. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst 1997;89: 932-8.
8. Risch HA. Re: Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer [letter]. J Natl Cancer Inst 1997;89:1726-7.
9. Schildkraut JM, Bastos E, Halabi S, Berchuck A. Re: Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer [authors' response]. J Natl Cancer Inst 1997;89:1727.
10. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control studs. Survey of Women's Health Study Group. Int J Cancer 1995;62:678-84.
11. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-8.
12. Lee J. Odds ratio or relative risk for cross-sectional data? [letter]. Int J Epidemiol 1994; 23:201-3.
13. Pettersson F, editor. Annual report on gynecologic cancer of FIGO. Vol 20. Stockholm: Panorama Press; 1988.